ASM Technologies Ltd
ASMTECASM Technologies Ltd's earnings have outrun its stock. EPS grew +88.6% in a year against a +68.3% price move.
The sharpest disagreement: the engine is strong, but at the 88th percentile of its own range you are paying full price for it.
The price is in a confirmed uptrend (14 weeks in) while the P/E sits at the 88th percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +68.8% year on year, and 70% of the last 3 years' profit arrived as cash. What settles it: whether the earnings grow into the multiple.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
ASM Technologies Ltd trades at ₹4,596, in a confirmed uptrend and 14 weeks into that stage. That is +33.0% against its own 200-day average. It sits at 93% of a 52-week range of ₹1,428 to ₹4,849. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 8 straight weeks.
Today the stock is in a confirmed uptrend — week 14 of stage 2, confirmed. At ₹4,596 it trades +33.0% versus its 200-day average and sits at 93% of its 52-week range (₹1,428–₹4,849).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +5,804% while the NIFTY 500 moved +277% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 8 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
ASM Technologies Ltd trades at 91.8× P/E, at the pricey end of its own range (88th percentile). Its long-run median P/E is 43.4×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 91.8× is at the pricey end of its own range (88th percentile), against a long-run median of 43.4× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +88.6% against a +68.3% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the +78.4%/yr price move, ~+47.1%/yr came from earnings growth and ~+31.3 pp from the multiple (expanding); over 10y, of the +55.0%/yr price move, ~+24.7%/yr came from earnings growth and ~+30.3 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 13 June 2026 price, ASM Technologies Ltd was paying for profit growth of about 28.3% a year. Profit itself has compounded 26.1% a year over the past 10 years. Today the market pays 91.8× P/E, the 88th percentile of its own 10-year range.
What the two numbers say together. The multiple is full against its own past, and the growth the price is paying for is close to what this company has actually delivered.
How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 25 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
ASM Technologies Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 8 quarters across 2 curves, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +83.0% | +34.0% | +31.0% | +23.7% |
| Profit | +144.0% | +105.8% | +46.6% | +26.1% |
| EPS | +88.6% | +68.7% | +40.0% | +22.4% |
| Share price | +68.3% | +114.0% | +78.4% | +55.0% |
4-Factor Sector Score
65.4/100 — rank 3 of 48 in IT - Software · 69% evidence confidence
ASM Technologies Ltd scores 65.4 out of 100 against the 48 companies it is compared with in IT - Software, ranking 3. Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
The four contributions add to the total exactly: 28.9 + 16.3 + 8.8 + 11.4 = 65.4. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
ASM Technologies Ltd reported ₹199 Cr of revenue in the Jun 26 quarter, +61.8% year on year. That is the 9th straight quarter of year-on-year growth. Over 10 years it has compounded at 23.7% a year. The last full year, FY26, came in at ₹529 Cr. The last four reported quarters add to ₹604 Cr.
FY26 revenue came in at ₹529 Cr (+83.0% on the year), capping 10 years at 23.7% compound. The latest quarter (Jun 26) printed ₹199 Cr, +61.8% year on year — the 9th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +82.0% growth against the decade's 23.7% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +67.8% over the last 4 quarters against +72.1%/yr over the last 8 — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
ASM Technologies Ltd's operating margin is 23.0% in the Jun 26 quarter, +2.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 13 fiscal years the operating margin has ranged −10.0% to 19.0%. The current quarter is running above every full year in that window.
The latest quarter's operating margin is 23.0%, +2.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −10.0%–19.0%, and FY26's 19.0% is the top of that band — a record year.
Why the margin moved: operating margin went +2.3 pp year on year while gross margin went −12.1 pp — the gain came mostly from the gross line: input costs and pricing.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
ASM Technologies Ltd earned ₹27.0 Cr of net profit in the Jun 26 quarter, +68.8% year on year. It is the 5th consecutive quarter of growth. Full-year FY26 profit was ₹61.0 Cr. The 10-year compound rate is 26.1%. That is 13.6% of the quarter's revenue. The same quarter a year earlier earned ₹16.0 Cr.
Jun 26 profit was ₹27.0 Cr, +68.8% year on year — the 5th consecutive quarter of growth. On the full year, FY26 printed ₹61.0 Cr (+144.0%), and the 10-year compound rate is 26.1%.
Why profit moved: revenue contributed +61.8% and the margin +2.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +253.0% vs revenue +82.0%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 70% of ASM Technologies Ltd's reported profit arrived as operating cash — most of the profit is real cash. In FY26 that was ₹68.0 Cr of operating cash against ₹61.0 Cr of profit. After ₹65.0 Cr of capital spending, ₹3.0 Cr was left as free cash.
FY26: operating cash of ₹68.0 Cr against reported profit of ₹61.0 Cr, leaving free cash of ₹3.0 Cr after ₹65.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 70% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 70%: the cash cycle stretched 69 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: conversion is below par and the cash cycle has stretched 69 days — the next section's job is to find where the cash is stuck.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
ASM Technologies Ltd's cash conversion cycle runs 202 days in FY26, up from 133 days in FY21. Capital spending ran ₹113 Cr over the last 3 years. At FY26 sales of ₹529 Cr each day of that cycle holds about ₹1.4 Cr, so roughly ₹293 Cr sits inside the business at any moment.
FY26: debtors at 80 days, inventory at 204 days — roughly 6.7 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 202 days, looser than FY21's 133.
The full loop: cash goes out to suppliers and production on day 0; stock waits 204 days to sell; customers pay about 80 days after that; and suppliers themselves are paid at 82 days — netting out to the 202-day cycle.
In money terms: at FY26 sales of ₹529 Cr, each day of the cycle holds about ₹1.4 Cr — so the 202-day loop keeps roughly ₹293 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹113 Cr over the last 3 fiscal years against ₹35.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹7.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
ASM Technologies Ltd earns a ROCE of 27% in FY26. That is up from a trough of −1% in FY24. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 11.5% net margin on 1.05× asset turns.
FY26 ROCE is 27%, recovered from a FY24 trough of −1% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 11.5% net margin × 1.05× asset turns × 1.64× balance-sheet leverage ≈ 19.8% on equity. Margin does its share; leverage is a meaningful part of the equation.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
ASM Technologies Ltd carries ₹128 Cr of borrowings against ₹307 Cr of equity in FY26, a debt-to-equity of 0.42. Operating profit covers the interest bill 11×. Over 5 years borrowings went from ₹35.0 Cr to ₹128 Cr. Capital spending ran ₹113 Cr across the last 3 of those years.
FY26: borrowings of ₹128 Cr against equity of ₹307 Cr — a debt-to-equity of 0.42. Operating profit covers the interest bill 11×. Over 5 years borrowings went from ₹35.0 Cr to ₹128 Cr while capital spending ran ₹113 Cr in just the last 3 — part of the build-out is riding on borrowed money.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters cut 3.9 points of ASM Technologies Ltd over 8 quarters, the biggest move on the register. That takes promoters to 57.6% of the company. Domestic institutions moved +0.7 points over the same window, to 0.7%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: −3.9 points over 8 quarters to 57.6%; Domestic institutions: +0.7 points over 8 quarters to 0.7%; Foreign institutions: +0.2 points over 8 quarters to 0.5%.
🚨 Why the register moved: promoters drove it (−3.9 points), absorbed on the other side by domestic institutions (+0.7 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
ASM Technologies Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Silver Touch Technologies LtdSILVERTUC | 71.8/100Favorable setup93% evidence | ASLEEP | 31.0/35 Revenue 21.1% · PAT 86.4% · OPM change 8 pp 100% evidence | 17.5/25 ROCE 29.8% · OPM 22% 100% evidence | 10.4/20 P/E 45× · PEG 1.11 65% evidence | 12.9/20 RS sector 9.1% · RS bench 9.4% · 1Y 103.8%7 of 12 weeks ahead 100% evidence |
| Exact sum: 31 + 17.5 + 10.4 + 12.9 = 71.8 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2NINtec Systems LtdNINSYS | 66.1/100Favorable setup80% evidence | ASLEEP | 20.6/35 Revenue 21.6% · PAT 18.8% · OPM change 4.2 pp 95% evidence | 22.2/25 ROCE 54% · OPM 25.9% 95% evidence | 9.2/20 P/E 39.2× · PEG — 15% evidence | 14.1/20 RS sector 36.6% · RS bench 35.8% · 1Y 57.9%7 of 12 weeks ahead 100% evidence |
| Exact sum: 20.6 + 22.2 + 9.2 + 14.1 = 66.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3ASM Technologies Ltdthis pageASMTEC | 65.4/100Favorable setup69% evidence | 28.9/35 Revenue 67.8% · PAT 89.5% · OPM change 2 pp 95% evidence | 16.3/25 ROCE 27% · OPM 23% 76% evidence | 8.8/20 P/E 91.8× · PEG — 15% evidence | 11.4/20 RS sector -4.8% · RS bench 31.7% · 1Y 10.3%0 of 12 weeks ahead to 2026-08-23 70% evidence | |
| Exact sum: 28.9 + 16.3 + 8.8 + 11.4 = 65.4 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 4Datamatics Global Services LtdDATAMATICS | 64.2/100Mixed-positive evidence94% evidence | TURNING | 21.7/35 Revenue 13.1% · PAT 1.9% · OPM change 4 pp 100% evidence | 16.3/25 ROCE 20.4% · OPM 20% 100% evidence | 10.4/20 P/E 18.8× · PEG 0.69 100% evidence | 15.8/20 RS sector 11.7% · RS bench 4.3% · 1Y -10.7%4 of 11 weeks ahead 70% evidence |
| Exact sum: 21.7 + 16.3 + 10.4 + 15.8 = 64.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Cigniti Technologies LtdCIGNITITEC | 64.1/100Mixed-positive evidence73% evidence | 23.9/35 Revenue 14% · PAT 96.1% · OPM change 2 pp 56% evidence | 16.5/25 ROCE 34.1% · OPM 18% 75% evidence | 16.1/20 P/E 11.4× · PEG 0.61 100% evidence | 7.6/20 RS sector -8.9% · RS bench -15% · 1Y -25.7%0 of 12 weeks ahead to 2026-05-17 70% evidence | |
| Exact sum: 23.9 + 16.5 + 16.1 + 7.6 = 64.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6TAC Infosec LtdTAC | 63.6/100Mixed-positive evidence66% evidence | BREAKING OUT | 26.3/35 Revenue 76.4% · PAT 59.4% · OPM change 1.6 pp 71% evidence | 21.1/25 ROCE 38.1% · OPM 48.2% 95% evidence | 9.3/20 P/E 34.1× · PEG — 15% evidence | 6.9/20 RS sector -11.4% · RS bench -17.8% · 1Y -17.4%6 of 11 weeks ahead 70% evidence |
| Exact sum: 26.3 + 21.1 + 9.3 + 6.9 = 63.6 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -11.4% and the one-year return is -17.4%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 7Sasken Technologies LtdSASKEN | 63.4/100Mixed-positive evidence100% evidence | ASLEEP | 31.4/35 Revenue 67.8% · PAT 67.4% · OPM change 4 pp 100% evidence | 8.4/25 ROCE 9.9% · OPM 9% 100% evidence | 10.3/20 P/E 34.8× · PEG 0.68 100% evidence | 13.3/20 RS sector 11.7% · RS bench 11% · 1Y 12.9%6 of 12 weeks ahead 100% evidence |
| Exact sum: 31.4 + 8.4 + 10.3 + 13.3 = 63.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8R Systems International LtdRSYSTEMS | 61.5/100Mixed-positive evidence100% evidence | BASING | 20.0/35 Revenue 24.1% · PAT -1% · OPM change 3 pp 100% evidence | 17.0/25 ROCE 19.5% · OPM 18% 100% evidence | 17.7/20 P/E 13.3× · PEG 0.26 100% evidence | 6.8/20 RS sector -21.5% · RS bench -22.6% · 1Y -46.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20 + 17 + 17.7 + 6.8 = 61.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Danlaw Technologies India Ltd532329 | 60.7/100Mixed-positive evidence67% evidence | BREAKING OUT | 22.7/35 Revenue 24.1% · PAT 34.5% · OPM change 0.8 pp 95% evidence | 15.4/25 ROCE 27.6% · OPM 13.4% 76% evidence | 10.1/20 P/E 29.2× · PEG — 50% evidence | 12.5/20 RS sector — · RS bench 72.8% · 1Y —6 of 6 weeks ahead 25% evidence |
| Exact sum: 22.7 + 15.4 + 10.1 + 12.5 = 60.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Expleo Solutions LtdEXPLEOSOL | 60.5/100Mixed-positive evidence81% evidence | TURNING | 21.5/35 Revenue 10.4% · PAT 39.4% · OPM change 4 pp 95% evidence | 15.9/25 ROCE 24.2% · OPM 15% 95% evidence | 13.8/20 P/E 9.3× · PEG — 50% evidence | 9.3/20 RS sector -11.6% · RS bench 2.3% · 1Y -15%3 of 11 weeks ahead 70% evidence |
| Exact sum: 21.5 + 15.9 + 13.8 + 9.3 = 60.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11InfoBeans Technologies LtdINFOBEAN | 60.3/100Mixed-positive evidence87% evidence | FADING | 27.5/35 Revenue 35.5% · PAT 60.4% · OPM change 0 pp 95% evidence | 16.9/25 ROCE 29.2% · OPM 21% 95% evidence | 9.7/20 P/E 16.7× · PEG — 50% evidence | 6.2/20 RS sector -10% · RS bench -10.3% · 1Y 3.3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 27.5 + 16.9 + 9.7 + 6.2 = 60.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -10% and the one-year return is 3.3%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 12Infosys LtdINFY | 59.3/100Mixed-positive evidence82% evidence | BASING | 18.8/35 Revenue 11.2% · PAT 11.1% · OPM change 0 pp 95% evidence | 20.4/25 ROCE 40% · OPM 24% 76% evidence | 14.3/20 P/E 13× · PEG — 50% evidence | 5.8/20 RS sector -21.4% · RS bench -22.1% · 1Y -35.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.8 + 20.4 + 14.3 + 5.8 = 59.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Blue Cloud Softech Solutions LtdBLUECLOUDS | 57.1/100Mixed-positive evidence74% evidence | 22.5/35 Revenue 41.1% · PAT 36.2% · OPM change 10 pp 95% evidence | 12.8/25 ROCE 14.2% · OPM 20% 95% evidence | 9.4/20 P/E 31.9× · PEG — 15% evidence | 12.4/20 RS sector -2.7% · RS bench 7.2% · 1Y -23.3%1 of 12 weeks ahead 70% evidence | |
| Exact sum: 22.5 + 12.8 + 9.4 + 12.4 = 57.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14LTM LtdLTM | 56.1/100Mixed-positive evidence100% evidence | BREAKING OUT | 18.1/35 Revenue 13.9% · PAT 10% · OPM change 1 pp 100% evidence | 17.9/25 ROCE 29.6% · OPM 18% 100% evidence | 10.6/20 P/E 21.6× · PEG 1.18 100% evidence | 9.5/20 RS sector -13% · RS bench -14% · 1Y -25.9%7 of 12 weeks ahead 100% evidence |
| Exact sum: 18.1 + 17.9 + 10.6 + 9.5 = 56.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Xchanging Solutions LtdXCHANGING | 54.9/100Mixed-positive evidence81% evidence | TURNING | 19.3/35 Revenue 8.4% · PAT 13.2% · OPM change 1 pp 95% evidence | 15.8/25 ROCE 18% · OPM 34% 95% evidence | 14.1/20 P/E 11.2× · PEG — 50% evidence | 5.7/20 RS sector -22.8% · RS bench -10.3% · 1Y -31.3%0 of 11 weeks ahead 70% evidence |
| Exact sum: 19.3 + 15.8 + 14.1 + 5.7 = 54.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Saksoft LtdSAKSOFT | 53.9/100Mixed-positive evidence100% evidence | ASLEEP | 18.6/35 Revenue 8.2% · PAT 13% · OPM change 0 pp 100% evidence | 15.8/25 ROCE 25.5% · OPM 18% 100% evidence | 13.5/20 P/E 14× · PEG 0.6 100% evidence | 6.0/20 RS sector -10.3% · RS bench -11.5% · 1Y -35.9%10 of 12 weeks ahead 100% evidence |
| Exact sum: 18.6 + 15.8 + 13.5 + 6 = 53.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Tata Consultancy Services LtdTCS | 53.7/100Mixed-positive evidence100% evidence | BREAKING OUT | 10.6/35 Revenue 7.7% · PAT 1.1% · OPM change -1 pp 100% evidence | 22.9/25 ROCE 63% · OPM 26% 100% evidence | 12.2/20 P/E 14× · PEG 1.85 100% evidence | 8.0/20 RS sector -18% · RS bench -18.8% · 1Y -34.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 10.6 + 22.9 + 12.2 + 8 = 53.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18AvenuesAI LtdCCAVENUE | 53.5/100Mixed-positive evidence93% evidence | FADING | 21.6/35 Revenue 100% · PAT 43.8% · OPM change -2.3 pp 100% evidence | 5.3/25 ROCE 7.7% · OPM 3.7% 100% evidence | 14.8/20 P/E 18.7× · PEG 0.37 65% evidence | 11.8/20 RS sector 1.2% · RS bench 0.3% · 1Y -2.5%11 of 12 weeks ahead 100% evidence |
| Exact sum: 21.6 + 5.3 + 14.8 + 11.8 = 53.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19TechNVision Ventures LtdTECHNVISN | 53.3/100Mixed-positive evidence74% evidence | ASLEEP | 26.7/35 Revenue 23.4% · PAT 100% · OPM change 2.9 pp 95% evidence | 6.0/25 ROCE 13.6% · OPM 5.2% 95% evidence | 8.5/20 P/E 852× · PEG — 15% evidence | 12.1/20 RS sector 33.7% · RS bench -23.6% · 1Y -18.4%0 of 11 weeks ahead 70% evidence |
| Exact sum: 26.7 + 6 + 8.5 + 12.1 = 53.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20HCL Technologies LtdHCLTECH | 52.4/100Mixed-positive evidence82% evidence | BREAKING OUT | 12.8/35 Revenue 12.6% · PAT 2.6% · OPM change 0 pp 95% evidence | 19.1/25 ROCE 30.4% · OPM 20% 76% evidence | 9.0/20 P/E 18.8× · PEG — 50% evidence | 11.5/20 RS sector -6.7% · RS bench -7.5% · 1Y -14.3%9 of 12 weeks ahead 100% evidence |
| Exact sum: 12.8 + 19.1 + 9 + 11.5 = 52.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21Zensar Technologies LtdZENSARTECH | 51.5/100Mixed-positive evidence100% evidence | TURNING | 16.3/35 Revenue 8% · PAT 15.3% · OPM change 0 pp 100% evidence | 13.9/25 ROCE 22.8% · OPM 15% 100% evidence | 14.7/20 P/E 12.4× · PEG 1.11 100% evidence | 6.6/20 RS sector -23.4% · RS bench -24.4% · 1Y -49.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.3 + 13.9 + 14.7 + 6.6 = 51.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Mphasis LtdMPHASIS | 51.4/100Mixed-positive evidence94% evidence | BREAKING OUT | 16.2/35 Revenue 13.7% · PAT 9.9% · OPM change -1 pp 100% evidence | 17.6/25 ROCE 22.1% · OPM 18% 100% evidence | 5.6/20 P/E 22× · PEG 2.19 100% evidence | 12.0/20 RS sector 2% · RS bench -7.7% · 1Y -25.4%3 of 11 weeks ahead 70% evidence |
| Exact sum: 16.2 + 17.6 + 5.6 + 12 = 51.4 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 23Mastek LtdMASTEK | 51.2/100Mixed-positive evidence82% evidence | FADING | 14.5/35 Revenue 6% · PAT 5% · OPM change 0 pp 95% evidence | 13.6/25 ROCE 17.7% · OPM 15% 76% evidence | 12.8/20 P/E 11.2× · PEG — 50% evidence | 10.3/20 RS sector -10.2% · RS bench -11.2% · 1Y -34.6%4 of 12 weeks ahead 100% evidence |
| Exact sum: 14.5 + 13.6 + 12.8 + 10.3 = 51.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Capillary Technologies India LtdCAPILLARY | 51.2/100Mixed-positive evidence63% evidence | TURNING | 28.2/35 Revenue 27.8% · PAT 135.8% · OPM change 5.8 pp 100% evidence | 4.3/25 ROCE 3.4% · OPM 15.7% 100% evidence | 8.7/20 P/E 93.1× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —1 of 11 weeks ahead 0% evidence |
| Exact sum: 28.2 + 4.3 + 8.7 + 10 = 51.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Dynacons Systems & Solutions LtdDSSL | 49.6/100Mixed-negative evidence87% evidence | ASLEEP | 17.6/35 Revenue 10.5% · PAT 16.2% · OPM change 3 pp 95% evidence | 15.7/25 ROCE 30.3% · OPM 13% 95% evidence | 8.3/20 P/E 15.3× · PEG — 50% evidence | 8.0/20 RS sector -2.8% · RS bench -3.1% · 1Y 4.6%4 of 12 weeks ahead 100% evidence |
| Exact sum: 17.6 + 15.7 + 8.3 + 8 = 49.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26Hexaware Technologies LtdHEXT | 49.0/100Mixed-negative evidence94% evidence | FADING | 14.8/35 Revenue 13% · PAT 1.2% · OPM change 4 pp 100% evidence | 17.7/25 ROCE 30.1% · OPM 16% 100% evidence | 10.4/20 P/E 21.4× · PEG 0.81 100% evidence | 6.1/20 RS sector -19.8% · RS bench -12.6% · 1Y -36.5%7 of 11 weeks ahead 70% evidence |
| Exact sum: 14.8 + 17.7 + 10.4 + 6.1 = 49 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27Wipro LtdWIPRO | 48.6/100Mixed-negative evidence100% evidence | BASING | 13.3/35 Revenue 6.4% · PAT -1.7% · OPM change 0 pp 100% evidence | 15.6/25 ROCE 17.8% · OPM 19% 100% evidence | 13.9/20 P/E 12.3× · PEG 1.4 100% evidence | 5.8/20 RS sector -19.6% · RS bench -20.4% · 1Y -35.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.3 + 15.6 + 13.9 + 5.8 = 48.6 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 28XT Global Infotech LtdXTGLOBAL | 47.9/100Mixed-negative evidence61% evidence | 18.8/35 Revenue 85.4% · PAT 29.4% · OPM change -6.6 pp 53% evidence | 9.5/25 ROCE 7.5% · OPM 9.5% 71% evidence | 8.9/20 P/E 40.8× · PEG — 50% evidence | 10.7/20 RS sector 0.9% · RS bench -12.7% · 1Y -33%2 of 12 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 18.8 + 9.5 + 8.9 + 10.7 = 47.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 29Sonata Software LtdSONATSOFTW | 47.3/100Mixed-negative evidence100% evidence | FADING | 9.6/35 Revenue 4% · PAT 7.9% · OPM change 0 pp 100% evidence | 13.8/25 ROCE 30.7% · OPM 5% 100% evidence | 13.0/20 P/E 15.5× · PEG 0.81 100% evidence | 10.9/20 RS sector -4.1% · RS bench -5.3% · 1Y -29%9 of 12 weeks ahead 100% evidence |
| Exact sum: 9.6 + 13.8 + 13 + 10.9 = 47.3 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 30Unicommerce eSolutions LtdUNIECOM | 47.3/100Mixed-negative evidence74% evidence | ASLEEP | 14.8/35 Revenue 38.4% · PAT 18.1% · OPM change -8.1 pp 95% evidence | 16.8/25 ROCE 21.1% · OPM 10.6% 95% evidence | 9.0/20 P/E 44.3× · PEG — 15% evidence | 6.7/20 RS sector -12.8% · RS bench -16.1% · 1Y -40.9%0 of 11 weeks ahead 70% evidence |
| Exact sum: 14.8 + 16.8 + 9 + 6.7 = 47.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 31Hypersoft Technologies Ltd539724 | 45.4/100Mixed-negative evidence67% evidence | FADING | 17.5/35 Revenue 100% · PAT 100% · OPM change 2.9 pp 71% evidence | 5.4/25 ROCE 4.8% · OPM 14% 76% evidence | 8.6/20 P/E 401× · PEG — 15% evidence | 13.9/20 RS sector 52.9% · RS bench 53.2% · 1Y 221.8%8 of 12 weeks ahead 100% evidence |
| Exact sum: 17.5 + 5.4 + 8.6 + 13.9 = 45.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 32Excelsoft Technologies LtdEXCELSOFT | 45.0/100Mixed-negative evidence60% evidence | TURNING | 12.7/35 Revenue 26.8% · PAT 4.2% · OPM change -1.8 pp 95% evidence | 12.4/25 ROCE 13.6% · OPM 16.3% 95% evidence | 9.9/20 P/E 20× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —1 of 11 weeks ahead 0% evidence |
| Exact sum: 12.7 + 12.4 + 9.9 + 10 = 45 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 33Magellanic Cloud LtdMCLOUD | 40.3/100Mixed-negative evidence81% evidence | ASLEEP | 10.2/35 Revenue 13.7% · PAT 6.7% · OPM change -7 pp 95% evidence | 14.3/25 ROCE 19.7% · OPM 28% 95% evidence | 12.1/20 P/E 12.9× · PEG — 50% evidence | 3.7/20 RS sector -53.5% · RS bench -21.2% · 1Y -70.4%5 of 12 weeks ahead 70% evidence |
| Exact sum: 10.2 + 14.3 + 12.1 + 3.7 = 40.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 34Kellton Tech Solutions LtdKELLTONTEC | 39.7/100Mixed-negative evidence87% evidence | BASING | 10.8/35 Revenue 9.5% · PAT 9.6% · OPM change -1 pp 95% evidence | 10.0/25 ROCE 15% · OPM 11% 95% evidence | 11.9/20 P/E 7.8× · PEG — 50% evidence | 7.0/20 RS sector -17.3% · RS bench -18.1% · 1Y -49.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 10.8 + 10 + 11.9 + 7 = 39.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 35Innovana Thinklabs LtdINNOVANA | 39.5/100Mixed-negative evidence81% evidence | TURNING | 8.7/35 Revenue 26% · PAT -39% · OPM change -32.5 pp 95% evidence | 11.8/25 ROCE 15.8% · OPM 17.6% 95% evidence | 8.4/20 P/E 20.2× · PEG — 50% evidence | 10.6/20 RS sector 1.5% · RS bench -19.3% · 1Y -45%0 of 11 weeks ahead 70% evidence |
| Exact sum: 8.7 + 11.8 + 8.4 + 10.6 = 39.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 36Aurionpro Solutions LtdAURIONPRO | 37.3/100Mixed-negative evidence93% evidence | ASLEEP | 13.9/35 Revenue 14.8% · PAT 5.1% · OPM change -3 pp 100% evidence | 11.2/25 ROCE 16.3% · OPM 17% 100% evidence | 10.2/20 P/E 17.7× · PEG 1.39 65% evidence | 2.0/20 RS sector -23.6% · RS bench -24.4% · 1Y -45.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.9 + 11.2 + 10.2 + 2 = 37.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 37Allied Digital Services LtdADSL | 37.2/100Mixed-negative evidence74% evidence | BASING | 15.1/35 Revenue 19.1% · PAT 5.6% · OPM change 0 pp 95% evidence | 6.6/25 ROCE 7.4% · OPM 9% 95% evidence | 10.3/20 P/E 16.8× · PEG — 15% evidence | 5.2/20 RS sector -28.4% · RS bench -9.6% · 1Y -41.9%0 of 11 weeks ahead 70% evidence |
| Exact sum: 15.1 + 6.6 + 10.3 + 5.2 = 37.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 38Mindteck (India) LtdMINDTECK | 34.2/100Adverse evidence87% evidence | BASING | 8.4/35 Revenue -1.8% · PAT 0.3% · OPM change -1.7 pp 95% evidence | 10.8/25 ROCE 15.1% · OPM 7.8% 95% evidence | 12.1/20 P/E 15.1× · PEG — 50% evidence | 2.9/20 RS sector -21.4% · RS bench -22.2% · 1Y -30.8%1 of 12 weeks ahead 100% evidence |
| Exact sum: 8.4 + 10.8 + 12.1 + 2.9 = 34.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 39Moschip Technologies LtdMOSCHIP | 32.9/100Adverse evidence87% evidence | TURNING | 7.8/35 Revenue 8.4% · PAT -33.6% · OPM change -3.9 pp 100% evidence | 7.5/25 ROCE 11% · OPM 8.2% 100% evidence | 3.6/20 P/E 125× · PEG 5.04 65% evidence | 14.0/20 RS sector 3.9% · RS bench -0.1% · 1Y -24.3%2 of 11 weeks ahead 70% evidence |
| Exact sum: 7.8 + 7.5 + 3.6 + 14 = 32.9 · Decision use: Price leads the evidence: RS versus the benchmark is -0.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 40Orient Technologies LtdORIENTTECH | 31.9/100Thin evidence · provisional54% evidence | BASING | 15.1/35 Revenue — · PAT — · OPM change -0.5 pp 19% evidence | 2.6/25 ROCE 8.4% · OPM 6.7% 95% evidence | 9.0/20 P/E 43.3× · PEG — 15% evidence | 5.2/20 RS sector -18.1% · RS bench -19% · 1Y -27.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.1 + 2.6 + 9 + 5.2 = 31.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 41Quick Heal Technologies LtdQUICKHEAL | 21.5/100Adverse evidence69% evidence | BASING | 6.1/35 Revenue -6.6% · PAT -80% · OPM change -22.1 pp 71% evidence | 1.9/25 ROCE -6% · OPM -39% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.5/20 RS sector -24.8% · RS bench -26.3% · 1Y -56.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 6.1 + 1.9 + 10 + 3.5 = 21.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 42Covance Softsol Ltd544361 | 67.4/100Thin evidence · provisional49% evidence | 26.1/35 Revenue 43.5% · PAT 100% · OPM change 19.7 pp 62% evidence | 18.0/25 ROCE 31.4% · OPM 23.1% 76% evidence | 11.0/20 P/E 12.9× · PEG — 15% evidence | 12.3/20 RS sector — · RS bench 48.4% · 1Y — 25% evidence | |
| Exact sum: 26.1 + 18 + 11 + 12.3 = 67.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 43Unified Data- Tech Solutions LtdUNIFIED | 56.6/100Thin evidence · provisional36% evidence | 17.0/35 Revenue — · PAT — · OPM change 1 pp 26% evidence | 18.9/25 ROCE 45.2% · OPM 15% 76% evidence | 10.2/20 P/E 18.6× · PEG — 15% evidence | 10.5/20 RS sector — · RS bench -1.2% · 1Y -6.6%0 of 12 weeks ahead to 2026-08-23 25% evidence | |
| Exact sum: 17 + 18.9 + 10.2 + 10.5 = 56.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 44Metalic Technoforge LtdMETA | 52.9/100Thin evidence · provisional27% evidence | 16.1/35 Revenue — · PAT — · OPM change -2 pp 13% evidence | 17.2/25 ROCE 36.1% · OPM 8% 76% evidence | 9.6/20 P/E 25.3× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y -20.4%0 of 12 weeks ahead to 2026-08-23 0% evidence | |
| Exact sum: 16.1 + 17.2 + 9.6 + 10 = 52.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 45Veefin Solutions LtdVEEFIN | 47.6/100Thin evidence · provisional50% evidence | 17.8/35 Revenue — · PAT — · OPM change -5.1 pp 19% evidence | 10.9/25 ROCE 9.8% · OPM 19.7% 76% evidence | 12.1/20 P/E 27.7× · PEG — 50% evidence | 6.8/20 RS sector -6.1% · RS bench -24.9% · 1Y -39.3%0 of 12 weeks ahead to 2026-08-23 70% evidence | |
| Exact sum: 17.8 + 10.9 + 12.1 + 6.8 = 47.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 46Trident Techlabs LtdTECHLABS | 46.1/100Thin evidence · provisional40% evidence | 16.0/35 Revenue — · PAT — · OPM change -2 pp 15% evidence | 16.3/25 ROCE 26.7% · OPM 27% 71% evidence | 10.6/20 P/E 14.9× · PEG — 15% evidence | 3.2/20 RS sector -49.2% · RS bench -56.5% · 1Y -69.5%0 of 12 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 16 + 16.3 + 10.6 + 3.2 = 46.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 47ERP Soft Systems Ltd530909 | 44.6/100Thin evidence · provisional41% evidence | 20.3/35 Revenue 19.1% · PAT 100% · OPM change -1.1 pp 53% evidence | 7.9/25 ROCE 1.6% · OPM 1.7% 57% evidence | 8.8/20 P/E 74.9× · PEG — 15% evidence | 7.6/20 RS sector — · RS bench -47.6% · 1Y -53.9%0 of 12 weeks ahead to 2026-03-29 25% evidence | |
| Exact sum: 20.3 + 7.9 + 8.8 + 7.6 = 44.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 48IDream Film Infrastructure Company Ltd504375 | 38.2/100Thin evidence · provisional35% evidence | 12.8/35 Revenue — · PAT 100% · OPM change — 33% evidence | 3.0/25 ROCE -9.2% · OPM -25.8% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.4/20 RS sector — · RS bench 71.8% · 1Y —8 of 8 weeks ahead 25% evidence | |
| Exact sum: 12.8 + 3 + 10 + 12.4 = 38.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is ASM Technologies Ltd's share price today?
ASM Technologies Ltd trades at ₹4,596, +68.3% over the past year. The company is valued at ₹6,704 Cr. The stock sits at 93% of its 52-week range of ₹1,428–₹4,849, +33.0% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 14 weeks in. — as of 25 September 2026.
What were ASM Technologies Ltd's latest quarterly results?
ASM Technologies Ltd reported revenue of ₹199 Cr and net profit of ₹27.0 Cr for the Jun 26 quarter. Revenue rose 61.8% and profit rose 68.8% year on year. Earnings per share were ₹18.39. The operating margin was 23.0%, 2.0 pp higher than a year earlier. — as of 25 September 2026.
What is ASM Technologies Ltd's revenue?
ASM Technologies Ltd reported revenue of ₹199 Cr in the Jun 26 quarter, +61.8% year on year. For the full FY26 fiscal year, revenue was ₹529 Cr (+83.0%). Over the last 10 years revenue compounded at 23.7% a year. — as of 25 September 2026.
What is ASM Technologies Ltd's profit?
ASM Technologies Ltd earned ₹27.0 Cr of net profit in the Jun 26 quarter, +68.8% year on year — the 5th straight quarter of growth. Full-year FY26 profit was ₹61.0 Cr. The operating margin ran 23.0% in the latest quarter. — as of 25 September 2026.
What is ASM Technologies Ltd's market cap?
ASM Technologies Ltd's market capitalisation is ₹6,704 Cr at a share price of ₹4,596. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 25 September 2026.
What is ASM Technologies Ltd's P/E ratio?
ASM Technologies Ltd trades at a P/E of 91.8×, at the 88th percentile of its own 10-year range, against a long-run median of 43.4×. This is a comparison with the stock's own history, not a value call — as of 25 September 2026.
Does ASM Technologies Ltd pay a dividend?
Yes — ASM Technologies Ltd's dividend payout was 40% of profit in FY26, and it recorded a payout in 11 of its last 13 reported fiscal years. 2 of those years show a negative ratio because profit itself was negative. This page holds the payout ratio, not a per-share amount. — as of 25 September 2026.
Is ASM Technologies Ltd overvalued?
On its own history, ASM Technologies Ltd looks expensive: its P/E of 91.8× sits at the 88th percentile of its 10-year range (long-run median 43.4×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 25 September 2026.
Is ASM Technologies Ltd growing?
Yes — ASM Technologies Ltd is growing: latest-quarter revenue +61.8% year on year, profit +68.8%, and the margin +2.0 pp at 23.0%. The 10-year compound rates are 23.7% (revenue) and 26.1% (profit). The earnings engine currently reads: improving — as of 25 September 2026.
How is ASM Technologies Ltd performing?
ASM Technologies Ltd is in a confirmed uptrend, 14 weeks in. Its latest quarter's revenue rose 61.8% and profit rose 68.8% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 8 weeks. This describes what the data did, not a rating. — as of 25 September 2026.
Is ASM Technologies Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 14 of stage 2), trading +33.0% versus its 200-day average and at 93% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 25 September 2026.
Is ASM Technologies Ltd beating the market?
On recent form, yes — ASM Technologies Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 8 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +5,804% against the NIFTY 500's +277% — ahead of the index over the full window. — as of 25 September 2026.
Will ASM Technologies Ltd's share price go up?
This page publishes no price forecast for ASM Technologies Ltd. What it measures instead: the share price is ₹4,596, the price is in a confirmed uptrend 14 weeks in. Its P/E of 91.8× sits at the 88th percentile of its own 10-year range. — as of 25 September 2026.
Who owns ASM Technologies Ltd?
Promoters hold 57.6% of ASM Technologies Ltd, foreign institutions 0.5%, domestic institutions 0.7% and the public 41.1% (latest quarter). The biggest move on the register over the last two years: Promoters cut 3.9 points over 8 quarters. — as of 25 September 2026.
Does ASM Technologies Ltd have too much debt?
It is moderate — ASM Technologies Ltd's debt-to-equity is 0.42, and operating profit covers the interest bill 11×. FY26 borrowings were ₹128 Cr against equity of ₹307 Cr. Read the returns on this page with that leverage in mind — as of 25 September 2026.
What is ASM Technologies Ltd's capex?
ASM Technologies Ltd spent ₹113 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹65.0 Cr, with ₹7.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 25 September 2026.
What is ASM Technologies Ltd's cash flow?
ASM Technologies Ltd generated ₹68.0 Cr of operating cash flow in FY26 and ₹3.0 Cr of free cash flow after ₹65.0 Cr of capital spending. Reported profit that year was ₹61.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 25 September 2026.
Is ASM Technologies Ltd's profit real cash?
Mostly — over the last 3 fiscal years, 70% of ASM Technologies Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹68.0 Cr against reported profit of ₹61.0 Cr. The cash then goes mostly into the working-capital cycle. Cash-flow resolution is annual — as of 25 September 2026.
Where is ASM Technologies Ltd in its business cycle?
ASM Technologies Ltd's FY26 operating margin was 19.0%, against a 13-year band of −10.0%–19.0%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 23.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 25 September 2026.
What growth does ASM Technologies Ltd's price assume?
At its price on 13 June 2026, ASM Technologies Ltd was priced for profit growth of about 28.3% a year. Profit itself has compounded 26.1% a year over the past 10 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 25 September 2026.
What could break the ASM Technologies Ltd story?
The sharpest disagreement: the engine is strong, but at the 88th percentile of its own range you are paying full price for it. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 25 September 2026.
Is ASM Technologies Ltd a stock worth studying right now?
This is not investment advice. The machine read: ASM Technologies Ltd's earnings have outrun its stock. EPS grew +88.6% in a year against a +68.3% price move. The sharpest open question: whether the earnings grow into the multiple. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 25 September 2026.
Not SEBI Registered !! Not Investment advice !!